Maria V. Sanchez
Mendoza, M, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG.
Journal: Pharmaceutics
Published: December 09, 2022
Receptor-binding domain-based SARS-CoV-2 vaccine adjuvanted with cyclic di-adenosine monophosphate enhances humoral and cellular immunity in mice.
Journal: Journal of medical virology
Published: July 06, 2022
Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis.
Journal: Frontiers in immunology
Published: November 29, 2021
Evaluation of different total Leishmania amazonensis antigens for the development of a first-generation vaccine formulated with a Toll-like receptor-3 agonist to prevent cutaneous leishmaniasis.
Journal: Memorias do Instituto Oswaldo Cruz
Published: February 13, 2020
100 Ma sweat bee nests: Early and rapid co-diversification of crown bees and flowering plants.
Journal: PloS one
Published: September 13, 2019
Total Leishmania antigens with Poly(I:C) induce Th1 protective response.
Journal: Parasite immunology
Published: July 03, 2017
Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge.
Journal: PloS one
Published: April 11, 2014
Development of a universal CTL-based vaccine for influenza.
Journal: Bioengineered
Published: January 23, 2013
Enhancement of Th1 immune responses to recombinant influenza nucleoprotein by Ribi adjuvant.
Journal: The new microbiologica
Published: November 19, 2012
Improved immune response to recombinant influenza nucleoprotein formulated with ISCOMATRIX.
Journal: Journal of microbiology and biotechnology
Published: March 28, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026